Clinical Trial Update: Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring wheat flour treatment using microbial transglutaminase and lysine ethyl ester for Celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Lysine ethyl ester (lysine ethyl ester)
• Microbial transglutaminase (microbial transglutaminase)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Celiac Disease | Phase 2 | Status: UNKNOWN